Type 2 Diabetes Mellitus
Conditions
Interventions
Conversion of premixed insulin to Insulin degludec/insulin aspart groups (Patients with type 2 diabetes who have been on a premixed insulin regimen for more than 3 months have been converted to Insuli
Sponsors
Peking University First Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. patients in the diabetes shared care management cohort of Peking University First Hospital (PKUFH) who completed the initial registration from October 2016 to December 2023 2. patients with type 2 diabetes; 3. aged >18 years; 4. application of premixed insulin or premixed insulin analogs for =3 months prior to conversion; 5. Insulin degludec/insulin aspart application for = 6 months after conversion.
Exclusion criteria
Exclusion criteria: 1. patients who, as of December 2023, have been withdrawn from follow-up in the diabetes shared care outpatient management cohort for various reasons; 2. patients with non-type 2 diabetes such as pre-diabetes, type 1 diabetes, and specific types of diabetes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change from baseline in HbA1c; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in daily glucose profiles before and after conversion;Change in total daily insulin dose before and after conversion;Change in total daily basal insulin component dose before and after conversion; | — |
Countries
China
Contacts
Public ContactLi Ang
Peking University First Hospital
Outcome results
None listed